ADIPOR1 and Alzheimer disease: Indeed, studies have found that inhibiting adiponectin receptor 1 (AdipoR1) leads to spatial learning and memory impairment, and AD-like pathological manifestations, including insulin signaling dysfunction, abnormal protein accumulation, and neuroinflammation (Kim et al., 2017).